Kimberly-Clark announced it will acquire Kenvue in a cash and stock transaction valued at $48.7 billion.
The deal brings together two iconic companies that will combine their portfolios of complementary products, including 10 billion-dollar brands, that touch nearly half the global population.
Based on current projections, the combined company would generate 2025 annual net revenues of approximately $32 billion and approximately $7 billion of adjusted EBITDA.
Kenvue, a Johnson & Johnson spinoff, is the world’s largest pure-play consumer health company, with brands including
Kimberly-Clark’s brands include
Author summary: Kimberly-Clark acquires Kenvue for $48.7 billion.